CHICAGO, IL – Sheridan Capital Partners, a Chicago-based lower middle-market private equity firm, announced today its investment in Canadian Orthodontic Partners (“COP,” or the “Company”), an orthodontics-focused Specialty Dental Support Organization (“SDSO”).
COP, headquartered in Toronto, provides management services to orthodontic practices throughout Canada. The Company’s back-office support enables orthodontists to focus on delivering the highest levels of patient care and provides a wide array of financing options to support treatment for patients.
“COP has been tremendously successful in growing and bringing the highest level of orthodontic care to patients across Canada, and we believe we can help accelerate that success,” said Jonathan Lewis, Partner of Sheridan Capital Partners. Sean Dempsey, Managing Director of Sheridan added, “This is another investment within our consumer/ retail healthcare thesis, and we are excited to have the opportunity to partner with Mike Black, Dr. John McManaman and the entire management team.”
Mike Black, CEO of COP, said, “Teaming up with Sheridan was an easy choice for us. The Sheridan team’s depth of experience in consumer healthcare, as well as their success growing Smile Doctors as an orthodontics-focused SDSO in the U.S. market, made the team ideal partners for the next stage of COP’s growth.” Dr. John McManaman, Chief Orthodontic Officer, added, “Our partnership with Sheridan gives us access to a team with best-in-class resources to accelerate COP’s growth in orthodontic practice management in Canada. Sheridan shares our commitment to excellence in the clinic as well as our vision for sustained growth in our core provinces and beyond.”
The transaction was led by Lewis, Dempsey, Tim Wheeler, Chase Culbertson, and Beau Brace. Terms of the transaction were not disclosed.
About Sheridan Capital Partners
Sheridan Capital Partners, headquartered in Chicago, Illinois, focuses on making private equity investments in leveraged buyouts, recapitalizations and large minority financings of growing lower middle market growth companies with enterprise values between $20 million and $150 million within the healthcare and consumer sectors.
Jonathan Lewis, Partner